ROCHESTER, N.Y., Feb. 19, 2021 /PRNewswire/ -- Vuzix®
Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a
leading supplier of Smart Glasses and Augmented Reality (AR)
technology and products, today announced that the Company's
Vuzix M400 Smart Glasses were featured in the American Medical
Association's Special COVID-19 Edition for Accelerating Change in
Medical Health Education Systems Science Student, Resident and
Fellow Impact Challenge. The clinical study was conducted by the
University of Louisville School of
Medicine and summarized in the recent publication by the American
Medical Association.
Shadowing and preceptorship opportunities allow students to get
an early idea of what specialty they would like to pursue. The
pandemic made it impossible for students around the country to
safely get the desired exposure to patients and practicing
physicians; making personal decisions regarding their specialty
they would plan to pursue difficult at best. The University of Louisville School of Medicine, during
the course of this clinical trial conducted in the spring of 2020,
was able to utilize Vuzix Smart glasses to enable approximately 320
students to receive a clinical shadowing experience which would
have been otherwise unavailable during the 2020 school year
for first year residents due to restrictions put in place as a
result of COVID-19.
Another key finding from the study was that using Vuzix Smart
Glasses to perform clinical shadowing provided an unprecedented
view of doctor-patient interaction and procedures that were
previously difficult to witness during conventional
shadowing. The Vuzix Smart Glasses provided students with
views of everything from suture technique to nuances in nonverbal
communication between patients and caretakers. As a result of
the clinical study, the University School of Medicine is currently
exploring how to implement smart glasses in gross anatomy labs to
supplement a virtual anatomy curriculum for third and fourth year
clinical faculties to record procedures, and perform demonstrations
to supplement their teaching.
"We're excited to see the impact our Vuzix M400 Smart Glasses
have had on the clinical experience for students at the
University of Louisville School of
Medicine to deliver new experiences in clinical shadowing that was
not available during conventional shadowing. Healthcare and
telemedicine is a rapidly evolving and very important market
vertical for business growth and innovation for Vuzix as we
continue to set the standard for industry-leading telemedicine
usage around the globe," said Paul
Travers, Vuzix President and Chief Executive Officer.
About Vuzix Corporation
Vuzix is a leading supplier of Smart-Glasses and Augmented
Reality (AR) technologies and products for the consumer and
enterprise markets. The Company's products include personal display
and wearable computing devices that offer users a portable
high-quality viewing experience, provide solutions for mobility,
wearable displays and augmented reality. Vuzix holds 184 patents
and patents pending and numerous IP licenses in the Video Eyewear
field. The Company has won Consumer Electronics Show (or CES)
awards for innovation for the years 2005 to 2021 and several
wireless technology innovation awards among others. Founded in
1997, Vuzix is a public company (NASDAQ: VUZI) with offices in
Rochester, NY, Oxford, UK, and Tokyo, Japan. For more information,
visit
Vuzix website, Twitter and Facebook pages.
Forward-Looking Statements Disclaimer
Certain statements contained in this news release are
"forward-looking statements" within the meaning of the Securities
Litigation Reform Act of 1995 and applicable Canadian securities
laws. Forward looking statements contained in this release relate
to the American Medical Association and University of Louisville School of Medicine's case
study report, further program expansion and uses of Vuzix M400
Smart Glasses capabilities, and among other things the Company's
leadership in the Smart Glasses and AR display industry. They are
generally identified by words such as "believes," "may," "expects,"
"anticipates," "should" and similar expressions. Readers should not
place undue reliance on such forward-looking statements, which are
based upon the Company's beliefs and assumptions as of the date of
this release. The Company's actual results could differ materially
due to risk factors and other items described in more detail in the
"Risk Factors" section of the Company's Annual Reports and MD&A
filed with the United States Securities and Exchange Commission and
applicable Canadian securities regulators (copies of which may be
obtained at www.sedar.com or www.sec.gov). Subsequent events
and developments may cause these forward-looking statements to
change. The Company specifically disclaims any obligation or
intention to update or revise these forward-looking statements as a
result of changed events or circumstances that occur after the date
of this release, except as required by applicable law.
Media and Investor Relations Contact:
Ed McGregor, Director of Investor
Relations, Vuzix Corporation ed_mcgregor@vuzix.com Tel: (585)
359-5985
Vuzix Corporation, 25 Hendrix Road, Suite A, West Henrietta, NY 14586 USA,
Investor Information – IR@vuzix.com www.vuzix.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/vuzix-smart-glasses-featured-in-american-medical-association-special-covid-19-edition-for-accelerating-change-in-medical-health-education-systems-science-student-resident-and-fellow-impact-challenge-301231809.html
SOURCE Vuzix Corporation